Dermata Therapeutics Stock Forecast

Hold candidate since Jul 10, 2026 Gain 0.75%

The Dermata Therapeutics, Inc. stock price gained 0.746% on the last trading day (Monday, 13th Jul 2026), rising from $1.34 to $1.35. During the last trading day the stock fluctuated 3.79% from a day low at $1.32 to a day high of $1.37. The price has been going up and down for this period, and there has been a 4.65% gain for the last 2 weeks. Volume fell on the last day by -41 thousand shares and in total, 24 thousand shares were bought and sold for approximately $32.02 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Dermata Therapeutics, Inc. stock with a 90% probability to be traded between $1.19 and $1.43 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

DRMA Signals & Forecast

The Dermata Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.36. On a fall, the stock will find some support from the long-term average at approximately $1.27. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -4.26%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Dermata Therapeutics, Inc. stock

Dermata Therapeutics, Inc. finds support from accumulated volume at $1.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0500 between high and low, or 3.79%. For the last week the stock has had daily average volatility of 8.86%.

Our recommended stop-loss: $1.29 (-4.60%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (DRMA) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Dermata Therapeutics, Inc. to open at $1.35, and during the day (based on 14 day Average True Range), to move between $1.30 and $1.40, which gives a possible trading interval of +/-$0.102 (+/-7.85%) up or down from last closing price. If Dermata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.36 (0.74%) than the support at $1.34 (0.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Dermata Therapeutics, Inc. stock A Buy?

Dermata Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.659 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $1.35 ( 0.247%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk